Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
Belgium is TOP biotech non-US hotspot

Genengnews, the US news agency for Genetic Engineering & Biotechnology, published a list of 12 non-US hotspots for biotechnology jobs. Belgium is …


CEO FLUIDDA wins Antwerp Young Enterpreneur of the Year prize

This year marked the 6th edition of the Antwerp Young Enterpreneur competition, highlighting the entrepreneurial spirit in the province’s younger …


AbbVie in top 10 Best Workplaces 2016

On March 15th, the Best Workplaces of 2016 in Belgium were awarded. AbbVie, as the sole biopharmaceutical company, ranks in the top 10. In a n…

POPULAR TAGS

Confo Therapeutics appoints Galapagos veteran as CSO

Written by LVS on in the category news with the tags .


VIB/VUB spin-off Confo Therapeutics has appointed Dr. Christel Menet as its new Chief Scientific Officer. Menet previously held the position of Director of Chemistry at biotech heavyweight Galapagos, where she was responsible for the full development of the company’s most advanced and successful molecule filgotinib. The JAK1 inhibitor, which has proven to be effective in both Crohn’s disease and rheumatoid arthritis, is currently preparing for phase III clinical trials.

“I am thrilled to join Confo Therapeutics at an exciting time, and am impressed by the broad applicability of the break-through CONFO® technology. It allows medically relevant GPCRs to be stabilized in their active signaling state, revealing new binding pockets accessible for drug discovery. I’m looking forward to contribute to the selection and direction of Confo Therapeutics’ pipeline candidates”, said Dr. Christel Menet.

GPCRs are attractive drug targets since they are involved in many essential cellular processes and diseases. By stabilizing the receptors with the CONFO® technology, GPCR that are currently considered undruggable can be targeted. This opens up treatment possibilities for diseases with high unmet medical needs.

More information at www.confotherapeutics.com

Read more about: .

RELATED ARTICLES
Belgium is TOP biotech non-US hotspot

Genengnews, the US news agency for Genetic Engineering & Biotechnology, published a list of 12 non-US hotspots for biotechnology jobs. Belgium is …


CEO FLUIDDA wins Antwerp Young Enterpreneur of the Year prize

This year marked the 6th edition of the Antwerp Young Enterpreneur competition, highlighting the entrepreneurial spirit in the province’s younger …


AbbVie in top 10 Best Workplaces 2016

On March 15th, the Best Workplaces of 2016 in Belgium were awarded. AbbVie, as the sole biopharmaceutical company, ranks in the top 10. In a n…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

GSK UGent Itera Life Science KU Leuven Biowin V-Bio Ventures Janssen Flanders.bio XpandInnovation Turnstone

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.